Duncan Barbara Gayle

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
12 Dec 24	OVID Ovid Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	1.06	90,000	95.40 k	90,000
21 Jun 24	AVIR Atea Pharmaceuticals	Stock Option Common Stock	Grant	Acquire A	No	No	3.44	41,200	141.73 k	41,200
21 Jun 24	AVIR Atea Pharmaceuticals	RSU Common Stock	Grant	Acquire A	No	No	0	29,600	0.00	29,600
16 Jun 24	AVIR Atea Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	0	33,150	0.00	33,150
16 Jun 24	AVIR Atea Pharmaceuticals	RSU Common Stock	Option exercise	Dispose M	No	No	0	33,150	0.00	0
4 Jun 24	FUSN Fusion Pharmaceuticals	Stock Option Common Stock	Sale back to company	Dispose D	No	No	4.64	17,000	78.88 k	0
4 Jun 24	FUSN Fusion Pharmaceuticals	Stock Option Common Stock	Sale back to company	Dispose D	No	No	3.6	17,000	61.20 k	0
4 Jun 24	FUSN Fusion Pharmaceuticals	Stock Option Common Stock	Sale back to company	Dispose D	No	No	8.15	17,000	138.55 k	0
4 Jun 24	FUSN Fusion Pharmaceuticals	Stock Option Common Stock	Sale back to company	Dispose D	No	No	12.4	30,000	372.00 k	0
25 Apr 24	HALO Halozyme Therapeutics	Common Stock	Grant	Acquire A	No	No	0	6,501	0.00	15,754

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.